Discussing Mindset Pharma’s 2022 Milestones and Future Plans with James Lanthier
Mindset's recent accomplishments have set the stage for its psychedelic drug candidates to be first in human clinical trials by 2023.
Similar Posts
How to Make Magic Mushroom Gummies
These magic mushroom gummies will make your life easier when it comes to dosing and masking the taste of mushrooms!
Consolidating Plant Medicine, Permaculture and Indigenous Wisdom With Colette Condorcita, Decriminalize Philadelphia
In this episode, Colette describes her diverse background working closely with plant medicines and Indigenous groups in South America, how psychedelics are intrinsically aligned with permaculture and the cultivation of sacred plants, and much more.
These Are the Best Areas to Forage for Psychedelic Mushrooms in the United States
A new study describes the Pacific Northwest as “by far the best place in America to go looking for psychedelic mushrooms.”
Psychedelic Business Spotlight – January 21
Catch up on some of the biggest psychedelic business developments that unfolded in the last week.
MindMed’s Patent STRATEGY & WHY Haven’t We Covered It YET? (MMED/ MNMD)
MindMed’s Patent STRATEGY & WHY Haven’t We Covered It YET? (MMED/ MNMD)
Patents and IP are important because it allows companies to protect their innovations and re-coup sunk costs into research and development by giving them a set period of time that only they can profit from any inventions they developed.
Given the importance of patents, some people have reached out and have asked why I haven’t talked about MindMed’ patents more.
For example, if you go to their Investors deck, you will see that MindMed, (MMED: NEO), (MNMD : NASDAQ), has 45+ different patent applications. We definitely haven’t done 45 videos on the matter. And that is because we actually don’t know what most of these patent applications are!
Enjoy the episode!
Follow us on social media! 🙌
Instagram: @thepsychedelicinvestor
Facebook: @thepsychedelicinvestor
Want to collaborate? Send us an email at:
thepsychedelicinvestor@gmail.com
Music from:
www.bensound.com
Video editing: @themyaholy
Check out our Benziga discounts
https://benzinga.grsm.io/jameshallifax1834
https://benzinga.grsm.io/thepsychedelicinvestor
DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.
All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.
#mindmed #mmed #mnmdstock
Psychedelic Use Associated with Reduced Risk of Heart Disease and Diabetes
Researchers say there are several ways classic psychedelics could, directly and indirectly, lead to improved cardiometabolic health.